FDA warns about use of certain glucose monitoring strips

It said that healthcare practitioners should not use GDH-PQQ (glucose dehydrogenase pyrroloquinoline quinine ) test strips on patients receiving therapeutic products containing non-glucose sugars. These sugars can falsely elevate glucose results, which may mask hypoglycemia or prompt excessive insulin administration, leading to a serious injury or death, the FDA said. Patients with serious medical conditions, including kidney failure and rheumatoid arthritis are most likely to use these therapies. Diabetics use glucose monitoring strips to test their blood sugar levels.

While long-term care professionals have at least two more weeks to agonize over the fate of a bill that would permanently repeal the current Medicare physicians funding formula, a host of other key funding "extenders" set to expire also hang in the balance.

Nearly four months into the year, a 2015 calendar sporting nude photographs of the residents of Pleasant Pointe Assisted Living in Akron, OH, are still flying out the door — so much so that a second printing was ordered.